How I manage priapism in chronic myeloid leukaemia patients

British Journal of Haematology
Ryan RodgersMhairi Copland

Abstract

Priapism is a rare presenting feature of chronic myeloid leukaemia (CML). It is a urological emergency requiring urgent treatment to prevent long-term complications, in particular erectile dysfunction. In males with CML, ischaemic priapism is believed to result from hyperleucocytosis and associated leucostasis or hyperviscosity, and is seen in patients presenting with a high white cell count. Increasingly, a combined modality approach is being used to treat CML patients presenting with priapism. This includes systemic therapy with chemotherapy (hydroxycarbamide or tyrosine kinase inhibitors) and therapeutic leukapheresis to reduce the white cell count as well as local intracavernous therapy. This review will examine the literature and discuss the presenting features, investigations and management of priapism in CML.

References

May 1, 1992·The Journal of Urology·G M Lomas, J P Jarow
Sep 1, 1991·The Journal of Urology·R J BoschE A Tanagho
Jan 1, 1991·The Journal of Urology·M R HamreJ R Humbert
Jan 1, 1991·The Journal of Urology·I Saenz de TejadaI Goldstein
Jun 1, 1989·The Journal of Urology·T R ShanthaA P Rodriquez
Jan 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B L PowellH B Muss
Jan 1, 1986·The Journal of Urology·M A Spycher, D Hauri
Jun 1, 1974·The Journal of Urology·S M SchreibmanH Grabstald
Feb 1, 1968·The Journal of Urology·G L KandelJ S Grove
Nov 1, 1980·Archives of Internal Medicine·A M EmondG R Serjeant
Jan 1, 1981·Transactions of the Royal Society of Tropical Medicine and Hygiene·G R Serjeant
Dec 1, 1981·Urology·G F Steinhardt, E Steinhardt
Jan 1, 1996·The Journal of Urology·N Muruve, D H Hosking
Nov 1, 1995·The Journal of Urology·A A SattarE Wespes
Sep 1, 1995·Urology·A K Ilkay, L A Levine
May 1, 1995·The Journal of Urology·C E RamosG S Benson
May 1, 1994·The Journal of Urology·M D BastubaI Goldstein
Aug 1, 1996·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·J P Mulhall, S C Honig
Aug 1, 1997·British Journal of Urology·I Ahmed, N A Shaikh
Jul 15, 1999·The New England Journal of Medicine·S FaderlH M Kantarjian
Dec 22, 1999·Journal of Pediatric Hematology/oncology·E MantadakisG R Buchanan
Dec 29, 2000·Annals of Hematology·S G MoranoG Alimena
May 19, 2001·Urology·I A ElandM J Sturkenboom
Jun 26, 2002·BJU International·S R KeoghaneM A W Miller
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Apr 1, 1960·The Journal of Urology·F HINMAN
Sep 23, 2003·The Journal of Urology·Drogo K MontagueUNKNOWN Americal Urological Association
Mar 5, 2004·International Journal of Impotence Research·S Priyadarshi
Mar 19, 2004·The Journal of Emergency Medicine·Gary M VilkeTheodore C Chan
May 12, 2004·Radiologic Clinics of North America·Hossein Sadeghi-NejadMamdouh A Mohamed
Jun 19, 2004·Pediatric Radiology·Hans-Joachim MentzelWerner A Kaiser
Sep 24, 2004·International Journal of Urology : Official Journal of the Japanese Urological Association·Allan PonniahPeter Taylor
Jan 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hunter C ChampionArthur L Burnett
Jun 11, 2005·The Journal of Urology·Drogo K MontagueUNKNOWN Erectile Dysfunction Guideline Update Panel
Nov 18, 2005·The Urologic Clinics of North America·Robert C Dean, Tom F Lue
Jan 21, 2006·The Journal of Sexual Medicine·John PryorWalter Stackl
Feb 8, 2006·Postgraduate Medical Journal·J CherianR Samman
Nov 23, 2006·European Urology·Trinity J BivalacquaArthur L Burnett
Mar 27, 2007·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Shahzad ShafiqueAndre A Kaplan

❮ Previous
Next ❯

Citations

Jan 23, 2016·Urology Case Reports·Rajendra B NerliM B Hiremath
Jan 30, 2015·The Journal of Sexual Medicine·Osama Kamal Zaki Mahmoud ShaeerOsama Mohamed Selim
Aug 29, 2012·British Journal of Haematology·Laura ChisickRajat Kumar
Oct 2, 2014·Hemoglobin·Naji S MallatAli T Taher
Dec 17, 2014·Cancer Control : Journal of the Moffitt Cancer Center·Laura S Connelly-Smith, Michael L Linenberger
Jan 31, 2014·MMW Fortschritte der Medizin·Andreas Schalhorn
Jul 18, 2017·Current Urology Reports·Bradley C HollandShaheen Alanee
Jun 24, 2017·Case Reports in Emergency Medicine·Michael R MincklerRichard Amini
Apr 19, 2019·International Journal of Impotence Research·Mark James JohnsonDavid James Ralph
Jan 7, 2020·Sexual Medicine Reviews·Oliver RalphDavid Ralph
Nov 26, 2020·Journal of Pediatric Hematology/oncology·Pallavi SachdevaAnupam Sachdeva

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Urology : Official Journal of the Japanese Urological Association
Allan PonniahPeter Taylor
BJU International
Pejman KheirandishShailesh Kulkarni
The Urologic Clinics of North America
Arthur L Burnett, Trinity J Bivalacqua
© 2021 Meta ULC. All rights reserved